Quest PharmaTech Inc. (QPTFF)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | 1.31 Million | 834.21 Thousand | 790.57 Thousand | 1.07 Million | 13.28 Million |
| Selling, General and Administrative Expenses | 772.95 Thousand | 497.98 Thousand | 620.33 Thousand | 857.84 Thousand | 2.37 Million |
| Research and Development Expenses | 542.86 Thousand | 336.22 Thousand | 170.23 Thousand | 212.5 Thousand | 11.26 Million |
| Other Expenses | - | 450 Thousand | 241.25 Thousand | 213.82 Thousand | - |
| Cost and Expenses | 1.31 Million | 834.21 Thousand | 790.57 Thousand | 1.07 Million | 13.28 Million |
| Operating Income | -1.31 Million | -834.21 Thousand | -58.3 Million | 163.31 Million | -13.63 Million |
| Interest Expense | 20.68 Thousand | 21 Thousand | 13.06 Thousand | 7766.00 | - |
| Income Tax Expense | - | -2.62 Million | -57.49 Million | 164.39 Million | -7.09 Million |
| Earnings before Tax | -3.01 Million | -64.88 Million | -85.03 Million | 190.06 Million | -13.25 Million |
| Net Income | -3.01 Million | -64.88 Million | -85.03 Million | 190.06 Million | -6.16 Million |
| Earnings Per Share Basic | -0.02 | -0.39 | -0.51 | 1.13 | -0.04 |
| Earnings Per Share Diluted | -0.02 | -0.39 | -0.51 | 1.11 | -0.04 |
| Weighted Average Shares Outstanding | 169.13 Million | 168.39 Million | 168.23 Million | 170.92 Million | 167.12 Million |
| Weighted Average Shares Outstanding (Diluted) | 169.12 Million | 168.39 Million | 168.23 Million | 170.92 Million | 167.4 Million |
| Gross Margin | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - |
| Profit Margin | - | - | - | - | - |
| EBITDA | -1.31 Million | -3.46 Million | -788.7 Thousand | -1.06 Million | -13.62 Million |
| Earnings Before Tax Margin | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 179.64 Thousand | 115.17 Thousand | 352.51 Thousand | 1.31 Million | 156.56 Thousand | 609.01 Thousand |
| Selling, General and Administrative Expenses | 119.25 Thousand | 50.63 Thousand | 295.37 Thousand | - | 94.73 Thousand | 258.99 Thousand |
| Research and Development Expenses | 60.39 Thousand | 64.53 Thousand | 57.13 Thousand | - | 61.82 Thousand | 350.02 Thousand |
| Other Expenses | 75 Thousand | 75 Thousand | -5000.00 | 170.71 Thousand | - | 141.81 Thousand |
| Cost and Expenses | 179.64 Thousand | 115.17 Thousand | 352.51 Thousand | 1.31 Million | 156.56 Thousand | 609.01 Thousand |
| Operating Income | -179.64 Thousand | -115.17 Thousand | -352.51 Thousand | -1.31 Million | -156.56 Thousand | -609.01 Thousand |
| Interest Expense | 6098.00 | 6058.00 | 5461.00 | 20.68 Thousand | 5572.00 | 5291.00 |
| Income Tax Expense | 6098.00 | 6058.00 | 5461.00 | -324.87 Thousand | 5572.00 | -9.49 Million |
| Earnings before Tax | 719.56 Thousand | -861.32 Thousand | 14.48 Million | -3.01 Million | -2.51 Million | -9.81 Million |
| Net Income | 719.56 Thousand | -861.32 Thousand | 14.48 Million | -3.01 Million | -2.51 Million | -9.81 Million |
| Earnings Per Share Basic | 0.00 | -0.01 | 0.09 | - | -0.01 | -0.06 |
| Earnings Per Share Diluted | 0.00 | -0.01 | 0.09 | - | -0.01 | -0.06 |
| Weighted Average Shares Outstanding | 169.15 Million | 169.15 Million | 169.13 Million | 169.13 Million | 169.14 Million | 169.13 Million |
| Weighted Average Shares Outstanding (Diluted) | 169.12 Million | 169.12 Million | 169.12 Million | 169.12 Million | 169.12 Million | 169.12 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | 329.4 Thousand | -795.74 Thousand | 15.58 Million | - | -1.9 Million | -10.1 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
F-PC
FNLC
0QPU
OTCO
BGLOBAL
PTOI